| 111 |
Serum and urine monocyte chemoattractant protein-1 as a markers for lupus nephritis. |
2020 |
| 112 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 113 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 114 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 115 |
Soluble human leukocyte antigen-G
evaluation in pregnant women with
gestational diabetes mellitus |
2020 |
| 116 |
The associations among RARRES2
rs17173608 gene polymorphism, serum
chemerin, and non-traditional lipid profile
in patients with metabolic syndrome |
2020 |
| 117 |
The associations among RARRES2
rs17173608 gene polymorphism, serum
chemerin, and non-traditional lipid profile
in patients with metabolic syndrome |
2020 |
| 118 |
Value of Platelet Distribution Width and Mean Platelet Volume in Disease Activity Score of Rheumatoid Arthritis |
2020 |
| 119 |
Vitamin D in active systemic lupus
erythematosus and lupus nephritis: a
forgotten player
|
2020 |
| 120 |
Association of Treg and TH17 Cytokines with HCV Pathogenesis and Liver Pathology
|
2019 |